• January 3, 2017
    OSLO, NORWAY – Jan. 3, 2017 - PHARMAQ, a business of Zoetis, today announced the acquisition of the Norwegian  company Nordland Sett Vaks, an innovator in the manufacture and marketing of high quality vaccination machinery for the aquaculture industry. Nordland Sett Vaks is based in Nesna, Norway, and offers a wide range of fish vaccination services and sale of vaccination machines to fish farming companies in Norway, the UK and in the Mediterranean region. Terms of the transaction weremore...
  • April 28, 2016
    GUILDFORD, SURREY, UK - April 27, 2016 - Zoetis and the University of Surrey today launched the Veterinary Health Innovation Engine (vHive), a novel multi-disciplinary centre designed to promote the development and adoption of digital innovation in animal health.Digital technologies including wearables, apps, sensors and satellites promise to transform real-time information capture for animal owners and their veterinary advisors.  This will enable improved understanding of animal healthmore...
  • March 30, 2016
    FLORHAM PARK, N.J., March 30, 2016 — Zoetis Inc. today announced that the U.S. Department of Agriculture (USDA) has granted the company a conditional license for Avian Influenza Vaccine, H5N1 Subtype, Killed Virus*. The vaccine is intended for use in chickens as an aid in the prevention of disease caused by avian influenza H5N1.“We stand ready to help our customers implement a vaccination strategy, should the USDA determine that is the best course of action for the industry,” said Jonmore...
  • November 10, 2015
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that it has completed the purchase of PHARMAQ, the global leader in vaccines and innovation for health products in aquaculture, for a price of $765 million on a debt-free basis, having fulfilled all closing requirements. Zoetis purchased PHARMAQ from a company owned by Permira IV, a fund managed by the global investment firm Permira, which has been the majority owner of the companymore...
  • November 2, 2015
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced an agreement to purchase PHARMAQ, the global leader in vaccines and innovation for health products in aquaculture, for a price of $765 million on a debt-free basis. Acquiring PHARMAQ strengthens Zoetis’ core livestock business, giving the company a market-leading presence in the fastest growing segment of the animal health industry. Zoetis is purchasing PHARMAQ from a company owned by Permira IV, amore...
  • July 30, 2015
    Complements Zoetis’ Embrex® In Ovo Vaccine Delivery System, Enabling Full Automation Solutions for Hatcheries DURHAM, N.C. – July 30, 2015 - Zoetis Inc. today announced an agreement to acquire KL Products, Inc. to strengthen its automation technology for poultry hatchery operations.  The privately held company headquartered in London, Ontario, Canada, is a leader in automation systems for the poultry industry. Terms of the transaction were not disclosed.The acquisition enablesmore...
  • March 19, 2015
    LONDON, UK - March 19, 2015 - Leading animal health company Zoetis Inc. unveiled its Centre for Digital Innovation (CDI) at the House of Lords today. Opened in the heart of London’s Tech City, the new Centre will create sophisticated digital products that enable data-driven decision-making to enhance precision farming and improve animal wellbeing for livestock and pets.Hosted by Lord Trees, the event was introduced by Lord de Mauley and attended by industry representatives including themore...
  • January 12, 2015
    NOTTINGHAM, UK - Jan. 12, 2015 -The University of Nottingham has secured funding from Biotechnology and Biological Sciences Research Council (BBSRC) to undertake a four-year project with Zoetis, the leading global animal health company, with the aim of improving feed efficiency in pig farming.This new project builds on an ongoing partnership between The University of Nottingham and Zoetis and will focus on studies to help maximize muscle growth and improve the health of pig herds on farms.more...
  • January 7, 2015
    FLORHAM PARK, N.J., Jan. 7, 2015 — Fostera® PRRS, from Zoetis, is now licensed for whole herd protection against both the respiratory and reproductive forms of disease caused by porcine reproductive and respiratory syndrome (PRRS) virus.The new reproductive claim, recently granted by the U.S. Department of Agriculture (USDA), allows for vaccination of sows and gilts prebreeding to help provide protection against the reproductive form of the disease. The new respiratory claim allows formore...
  • November 24, 2014
    DURHAM, N.C. - November 24, 2014 – Zoetis Inc. today announced the reintroduction of Zoamix® (zoalene), a versatile synthetic anticoccidial for the prevention and control of coccidiosis in broilers and turkeys.“The U.S. poultry industry loses an estimated $600 million a year to coccidiosis[i], so the return of Zoamix could not be coming at a better time,” said Don Waldrip, DVM, DACPV, a senior technical services veterinarian with Zoetis.He noted that U.S. poultry producers have not seen a newmore...